ARTV — Artiva Biotherapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Artiva Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	25.4	161	103	77	185
Net Total Accounts Receivable
Net Total Receivables	—	0.468	0.525	1.76	0.146
Prepaid Expenses
Total Current Assets	26.1	162	105	79.8	189
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.39	4.08	27.6	24.6	20.4
Other Long Term Assets
Total Assets	29.2	170	133	105	210
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	5.76	19.3	25.6	12.2	12.3
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	12.7	42.4	57.3	50.7	22.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	16.5	128	75.7	54.4	187
Total Liabilities & Shareholders' Equity	29.2	170	133	105	210
Total Common Shares Outstanding